Tuomas
Kiviniemi
Associate Professor, Internal Medicine
MD, PhD, FESC
Contact
Areas of expertise
Cardiology
Clinical trials
Atrial fibrillation
Coronary artery disease
Percutaneous coronary intervention
Pacemaker
Anticoagulation
Bleeding;
Biography
As a clinical cardiologist with a specific research interest in atrial fibrillation (AF) and long-term complications after percutaneous and surgical procedures, I have established a research group, which includes 10 PhD students at present. From a clinical point of view, my specific focus is AF patients undergoing cardiac procedures.
Teaching
Cardiology, ECG, Echocardiography, Atrial fibrillation, Anticoagulation
Research
PI leads CAREFIB Consortium, which aims to reduce the burden of atrial fibrillation and its adverse outcome stroke in patients undergoing cardiac procedures. This consortium is divided into three major studies: a retrospective epidemiological CAREAVR study; a prospective CAREBANK biobank and a prospective LAA-CLOSURE trial.
Publications
Intracranial aneurysm is predicted by abdominal aortic calcification index: A retrospective case-control study (2021)
Atherosclerosis
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Minor troponin T elevation and mortality in patients with atrial fibrillation presenting to the emergency department (2021)
European Journal of Clinical Investigation
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Adherence to risk-assessment protocols to guide computed tomography pulmonary angiography in patients with suspected pulmonary embolism (2021)
European Heart Journal - Quality of Care and Clinical Outcomes
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study (2021)
Annals of Medicine
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Anticoagulation Therapy After Biologic Aortic Valve Replacement (2021)
Frontiers in Cardiovascular Medicine
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study (2021)
Annals of Medicine
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4-5 (2021)
Nephron Physiology
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery--LAA-CLOSURE trial protocol (2021)
American Heart Journal
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))
EKG-tapaus (2021)
Sydänääni: Suomen Kardiologisen Seuran Lehti
(Muu (O2))
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis (2020)
Thrombosis Research
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))